[1]
T. Tofail, “Navigating GIP/ GLP-1 pathophysiology and compounding impacts on T2DM care”, J. Assoc. Clin. Endocrinol. Diabetol. Bangladesh, vol. 4, no. 20, p. S28, Oct. 2025.